By NextBestFitOverdose crisis and gaps in addiction treatment
Overdoses kill tens of thousands each year; treatment with buprenorphine and methadone is restricted, and coverage gaps interrupt treatment.
Who's affected
Who is hurt
- People with substance use disorders and affected communities: Overdoses, treatment restrictions, and coverage gaps harm people and their families.
- Family caregivers and affected families: Overdoses, treatment restrictions, and coverage gaps harm people and their families.
Who gains while it lasts
- Hospitals, clinics, and care organizations: Unregulated treatment operators benefit from the treatment system’s gaps.
- Fraudulent operators and cybercriminals: Illicit drug markets benefit from ongoing substance use.
Under your mix of paths
Paths that fix or soften it
Using your saved plan. 0 paths picked.Edit all picks
Root causes
- Stigma
- Regulatory barriers
- Coverage churn
Related costs
Open questions
- Should addiction treatment be available without cost or prior authorization?
Solution paths (2)
Open a path for what it fixes, what it creates or worsens, who gains and who loses, precedents, and how it connects to other paths. See all paths as a decision tree.
Any clinician can prescribe buprenorphine; methadone available in pharmacies and primary care.
- +Overdose crisis and gaps in addiction treatment
- −Fraud and improper payments
- −Faces political, industry, or legal opposition
Harm reduction servicesChosen
Fund naloxone, drug checking, and supervised consumption sites.
- +Overdose crisis and gaps in addiction treatment
- −Faces political, industry, or legal opposition